SCHEMBL7573085

SCHEMBL7573085

CCCCCCCCCc1cc(=O)c2cc(O)ccc2o1

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.97
STS P08842 2/20 0.61
PPARG P37231 1/20 0.48
MAPT P10636 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
THRB P10828 1/20 0.48
HPGD P15428 1/20 0.48
CASP3 P42574 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
IP6K2 Q9UHH9 1/20 0.48
CSNK2A2 P19784 1/20 0.47
CSNK2B P67870 1/20 0.47
CSNK2A1 P68400 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673826 0.94 ALOX15 (0.92) ALOX15STSPPARGMAPTNPC1
SCHEMBL3663082 0.89 ALOX15 (0.78) ALOX15STSPPARGCYP3A4HPGD
SCHEMBL3658889 0.89 ALOX15 (0.78) ALOX15STSPPARGCYP3A4HPGD
SCHEMBL3657705 0.89 ALOX15 (0.78) ALOX15STSPPARGCYP3A4HPGD
SCHEMBL7573134 0.88 ALOX15 (0.81) ALOX15STSPPARGMAPTNPC1
SCHEMBL3658287 0.87 ALOX15 (0.80) ALOX15STSPPARGCYP3A4HPGD
SCHEMBL3661429 0.83 ALOX15 (0.72) ALOX15PPARGCYP3A4HPGDSMN1; SMN2
SCHEMBL937843 0.82 ALOX15 (0.71) ALOX15STSPPARGMAPTNPC1
SCHEMBL3660146 0.81 ALOX15 (0.66) ALOX15STSPPARGMAPTCYP3A4
SCHEMBL21166318 0.81 ALOX15 (0.66) ALOX15STSPPARGMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070059-B1 CHROMANONE AND THIOCHROMANONE DERIVATIVES NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6346626-B1 DRUGS FOR TREATMENT OF SKIN DISORDERS SUCH AS ACNE, SEBORRHEA, ANDROGENIC ALOPECIA AND HIRSUTISM, OR IN THE TOPICAL TREATMENT OF SQUAMOUS CELL CARCINOMA NOVARTIS AG (CH) 2002-02-12 US disclosed
EP-1070059-A1 CHROMANONE AND THIOCHROMANONE DERIVATIVES Novartis AG (CH) 2001-01-24 EP disclosed
WO-1999052890-A1 CHROMANONE AND THIOCHROMANONE DERIVATIVES NOVARTIS AG (CH) 1999-10-21 WO disclosed